Engineering of Escherichia coli for Lycopene Production Through Promoter Engineering

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 12, 2015-09 ,pp. : 1094-1103

Bentham Science Publishers

Access to resources Recommend Favorite

Expanding the bioprocessing toolbox of Escherichia coli through metabolic engineering and synthetic biology: an emerging glycosylation chassis

By Strutton Benjamin   Pandhal Jagroop   Wright Phillip Craig  

Pharmaceutical Bioprocessing, Vol. 1, Iss. 3, 2013-08 ,pp. : 221-224

Future Science

Access to resources Recommend Favorite

Clinical immunotoxicity of therapeutic proteins

By Descotes Jacques   Gouraud Aurore  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 12, 2008-12 ,pp. : 1537-1549

Informa Healthcare

Access to resources Recommend Favorite

Derivatives of Cephalothin that Inhibit Amppicillin Resistant Escherichia Coli

By  

Medicinal Chemistry, Vol. 3, Iss. 1, 2007-01 ,pp. : 45-49

Bentham Science Publishers

Access to resources Recommend Favorite

Uropathogenic Escherichia coli Mediated Urinary Tract Infection

By  

Current Drug Targets, Vol. 13, Iss. 11, 2012-10 ,pp. : 1386-1399

Bentham Science Publishers

Access to resources Recommend Favorite